Pharmaceuticals

Antibiotic Resistance Remains Prevalent in Ocular Staphylococcal Infections

Newest ARMOR study data helps inform clinicians when choosing a therapy to pursue in affected patients.
05/11/2022

Managing Pediatric Ocular Pathology

Safe treatment of these patients requires a comprehensive understanding of available therapeutics.
03/15/2022

Update your Glaucoma Prescribing Protocols

Treatment options continue to evolve, with new meds and methods to consider.
03/15/2022

Hearing Loss a Possible Complication of Thyroid Eye Disease Drug

A small case series of teprotumumab-treated patients experienced auditory changes and other otologic symptoms.
03/08/2022

Teprotumumab Promising as Treatment For Proptosis, Diplopia

Compared with placebo and methylprednisolone, the drug was associated with greater symptomatic improvement.
02/25/2022

Oral CAIs More Safe Than Many Believe

The risk of adverse events was comparable to that of topical formulations, study finds.
02/01/2022

First Presbyopia Eye Drop Approved

The pilocarpine agent improves near and intermediate acuity, according to manufacturer Allergan.
10/29/2021

TNS Safe Treatment for Ocular Pain

Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.
06/01/2021

Stay Alert for Systemic Med Surprises

Many ocular adverse effects may be hiding inside your patient’s pill bottle. Here’s a new way to think about them.
05/15/2021

Managing Miotics and Mydriatics

Take a closer look at old, new and future uses of these drugs.
05/15/2021

Upcoming Events

May 24, 2022

Early Identification and Timely Referral
Location: Virtual Event
Speakers: Carolyn Majcher, OD, FAAO, FORS, and Jonathan Jonisch, MD
7:00–8:00pm EST

Sponsored by Regeneron

Register here

June 10-11, 2022

Intrepid Presents: Innovations and Implementations in Practice
Location: Renaissance Newport Beach
Program Co-chairs: Nathan Lighthizer, OD, FAAO and John D. Gelles, OD, FIAO, FCLSA
Earn 14 LIVE COPE Credits (approval pending)

Register here

June 16, 2022

Establishing a Partnership in the Effective Management of Patients with Diabetic Retinal Disease
Location: The Palm Chicago
Speakers: Steven Ferrucci, OD, FAAO, and Dilsher Dhoot, MD
7:30–8:30pm CST

Sponsored by Regeneron

Register here